title: Thrombolytic therapy for cardiac arrest due to pulmonary embolism after varicose vein surgery.
abstract: Anticoagulant therapy is the mainstay in the management of venous thromboembolism. Nevertheless, the situation is entirely different in the patients with submassive or massive pulmonary embolism (PE) and cardiac arrest, and the diagnosis and therapy strategy for such conditions are lacking. This patient, who presented with a cardiac arrest event after varicose vein surgery, was diagnosed as acute pulmonary embolism. She survived after administration of 50 mg recombinant tissue plasminogen activator (rt-PA) for over half an hour, along with continued anticoagulant therapy. Unfortunately, gastrointestinal and cerebral hemorrhaging occurred during the process.
authors: Emergency Department, The First Affiliated Hospital of Wenzhou Medical College, PR China.
authors: Bing
authors: B
authors: Wu
authors: Guang-ju
authors: GJ
authors: Zhao
authors: Huan
authors: H
authors: Liang
authors: Zhong-qiu
authors: ZQ
authors: Lu
authors: Qiao-meng
authors: QM
authors: Qiu
authors: Ying-ru
authors: YR
authors: Lu
mesh_terms: D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006323:Heart Arrest / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology; D011655:Pulmonary Embolism / Q000150:complications* / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects; D014648:Varicose Veins / Q000601:surgery*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator